Pembrolizumab and Fatigue: Practical Strategies for Managing Energy

Fatigue is the most commonly reported side effect during pembrolizumab treatment. Unlike the profound exhaustion associated with chemotherapy, immunotherapy-related fatigue is often more variable - sometimes mild, sometimes limiting - and responds better to active management strategies. Understanding its causes is the first step to managing it well.

Why fatigue occurs

Several mechanisms contribute to fatigue during pembrolizumab treatment. Immune activation itself is energy-intensive: generating and sustaining an immune response draws on physiological resources. The underlying cancer also contributes, as do the psychological demands of being on active treatment. In some cases, fatigue is a symptom of an immune-related side effect - most commonly thyroid dysfunction or anaemia - rather than a direct effect of the drug itself.

This distinction matters. Fatigue that develops gradually over several cycles and is accompanied by feeling cold, weight gain, or difficulty concentrating may indicate hypothyroidism - a common and easily treated irAE. Fatigue accompanied by breathlessness or pallor may indicate anaemia. Both are detectable on routine blood tests.

When fatigue is normal and when to report it

Some degree of tiredness after each injection cycle is common and generally expected. It tends to peak in the first few days after treatment and improve before the next cycle. This pattern - tired for a few days, then recovering - is typical and does not usually require specific investigation.

Report fatigue to your clinical team if it is severe enough to limit daily activities, if it does not improve between cycles, if it is worsening progressively over successive cycles, or if it is accompanied by other new symptoms. These patterns may warrant blood test review or clinical assessment before the next dose.

Practical management strategies

Energy management - pacing activity and rest rather than pushing through or doing nothing - is one of the most effective approaches. The goal is to remain as active as your energy allows without triggering a significant crash. Short walks, gentle stretching, and maintaining daily routines where possible all support energy levels over time.

• Plan activities for your better-energy days, usually mid-cycle
• Avoid large meals when energy is low - smaller, more frequent eating is easier to manage
• Prioritise sleep quality: a consistent sleep schedule and a dark, cool environment help
• Stay hydrated - dehydration compounds fatigue
• Accept help when it is offered, particularly in the days after each injection

Home treatment and fatigue management

One practical advantage of home-based pembrolizumab is that you do not spend energy on travel and waiting rooms on treatment days. For patients managing significant fatigue, this difference - conserving the energy that would otherwise go on a hospital visit - is genuinely meaningful.